A whale with a lot of money to spend has taken a noticeably bearish stance on DexCom.
Looking at options history for DexCom DXCM we detected 11 strange trades.
If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish expectations and 81% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $126,090 and 8, calls, for a total amount of $267,637.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $95.0 to $130.0 for DexCom over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for DexCom's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of DexCom's whale activity within a strike price range from $95.0 to $130.0 in the last 30 days.
DexCom Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| DXCM | CALL | SWEEP | BEARISH | 12/15/23 | $115.00 | $75.4K | 1.5K | 230 |
| DXCM | PUT | TRADE | NEUTRAL | 08/18/23 | $130.00 | $66.1K | 984 | 40 |
| DXCM | CALL | SWEEP | BEARISH | 08/18/23 | $110.00 | $31.3K | 1.4K | 140 |
| DXCM | PUT | SWEEP | BEARISH | 01/19/24 | $95.00 | $30.4K | 395 | 1 |
| DXCM | PUT | TRADE | BULLISH | 12/15/23 | $115.00 | $29.5K | 309 | 33 |
Where Is DexCom Standing Right Now?
- With a volume of 538,045, the price of DXCM is up 2.99% at $113.49.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 78 days.
What The Experts Say On DexCom:
- Barclays has decided to maintain their Equal-Weight rating on DexCom, which currently sits at a price target of $138.
- Canaccord Genuity has decided to maintain their Buy rating on DexCom, which currently sits at a price target of $150.
- Citigroup has decided to maintain their Buy rating on DexCom, which currently sits at a price target of $150.
- Piper Sandler has decided to maintain their Overweight rating on DexCom, which currently sits at a price target of $160.
- Raymond James has decided to maintain their Strong Buy rating on DexCom, which currently sits at a price target of $154.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DexCom, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
